Two Sigma Securities’s VolitionRx Ltd VNRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-789
Closed -$3.19K 2425
2026
Q1
$3.19K Buy
789
+59
+8% +$282 ﹤0.01% 1540
2025
Q4
$3.73K Buy
+730
New +$5.54K ﹤0.01% 1356
2025
Q2
Sell
-1,074
Closed -$12.2K 2136
2025
Q1
$12.2K Sell
1,074
-1,372
-56% -$16.4K ﹤0.01% 1193
2024
Q4
$29.3K Buy
+2,446
New +$32.8K ﹤0.01% 1253
2024
Q2
Sell
-1,134
Closed -$17.2K 3705
2024
Q1
$17.2K Buy
1,134
+546
+93% +$10.7K ﹤0.01% 2688
2023
Q4
$8.43K Sell
588
-820
-58% -$12.1K ﹤0.01% 2844
2023
Q3
$19.4K Buy
1,408
+614
+77% +$15.2K ﹤0.01% 2576
2023
Q2
$22.1K Buy
794
+290
+58% +$9.54K ﹤0.01% 2492
2023
Q1
$19.3K Sell
504
-160
-24% -$6.7K ﹤0.01% 2369
2022
Q4
$32.2K Sell
664
-1,054
-61% -$40.9K ﹤0.01% 2219
2022
Q3
$47K Buy
+1,718
New +$65K ﹤0.01% 2190

Other funds holding VNRX

Two Sigma Securities's VNRX Position: Q2 2026 in Review

Two Sigma Securities sold out of VolitionRx Ltd (VNRX) in Q2 2026, closing a stake of 789 shares — an estimated $3.19K sold.

Two Sigma Securities first reported a position in VNRX in Q3 2022 and held it in 11 quarters. The position peaked at $47K in Q3 2022. 25 funds tracked by Wall St. Rank hold VNRX as of Q2 2026.

  • Two Sigma Securities reported no remaining VolitionRx Ltd position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 789 VolitionRx Ltd shares in Q2 2026, an estimated $3.19K.
  • Two Sigma Securities first reported a position in VolitionRx Ltd in Q3 2022 and held it in 11 quarters.
  • Two Sigma Securities's VolitionRx Ltd position peaked at $47K in Q3 2022.
  • 25 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.